Amanta Healthcare Limited (AMANTA) — Announcement | 6 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company submits audio recording of post-results conference call to exchanges
💡 Investor Takeaway
Shareholders can now access management's commentary from the latest results conference call via the company's website.

Amanta Healthcare Limited announced the availability of an audio recording from its post-results conference call held on August 6, 2026, hosted on its investor relations website. The filing confirms the recording is accessible at https://www.amanta.co.in/investor-meet and was submitted to BSE and NSE for record-keeping. This update provides investors with direct access to management commentary following recent financial results, enhancing transparency and enabling deeper analysis of performance and outlook.

📄 View Original Announcement (PDF)

About Amanta Healthcare Limited (AMANTA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹712.71 Cr P/E: 44.1 ROE: 15.2% ROCE: 14.1%

View full AMANTA stock details →

📡 Get AI alerts when AMANTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMANTA — Free

📊 More AMANTA filings

See all AMANTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMANTA files new disclosures

Track AMANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMANTA — Free

Free account · 2 AI queries/day